In 1984 Professor Dennis Chapman, CChem FRSC, FRS (1927-1999) establishes.
1994 - ProClear contact lens is launched.
1995 - Biocompatibles is floated on the London Stock Exchange (LSE:BII).
1998 - The BiodivYsio stent is launched.
2002 - The Eye Care Division is sold to the Cooper Companies Inc and The Cardiovascular Stent business is sold to Abbott Laboratories. £100m of capital is returned to shareholders.
2005 - Biocompatibles acquires CellMed.
2006 - The DC Bead® is launched.
2008 - Biocompatibles acquires BrachySciences.
2009 - Biocompatibles acquires MoleMateTM and the SIAscopy patents.